Surgical management of proximal bile duct cancer:: extended right lobe resection increases resectability and radicality

被引:127
作者
Neuhaus, P
Jonas, S
Settmacher, U
Thelen, A
Benckert, C
Lopez-Hänninen, E
Hintze, RE
机构
[1] Humboldt Univ, Klin Allgemein Viszeral & Transplantat Chirurg, Charite, D-13353 Berlin, Germany
[2] Humboldt Univ, Strahlenklin & Poliklin, Charite, D-13353 Berlin, Germany
[3] Humboldt Univ, Zent Interdisziplinare Endoskopie Med Klin Schwer, Charite, D-13353 Berlin, Germany
关键词
bile duct cancer; Klatskin tumor; central bile duct resection; extended surgery for biliary cancer;
D O I
10.1007/s00423-003-0383-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Surgical resection provides the only chance of cure for patients suffering from hilar cholangiocarcinoma. Although appropriate procedures are not agreed upon, an increase in radicality has been observed during the past 20 years. Methods: The literature as well as our own experience after 133 resections of hilar cholangiocarcinomas were reviewed. Results: Tumor-free margins represent the most important prognostic parameter. Hilar resections a's least radical resective procedure will generate rates of formally curative resections of less than 50%. Even after these formally curative resections, long-term survival cannot be achieved. Only additional liver resections will increase the number of long-term survivors to significant figures. In our series, the best 5-year survival rate of 72% was achieved after right trisegmentectomy with concomitant resection of the portal vein bifurcation. Conclusion: Right trisegmentectomy and combined portal vein resection represent the best way to comply with basic rules of surgical oncology for hilar cholangiocarcinoma. This procedure will provide the most pronounced benefit among various types of liver resection, whereas local resections of the extrahepatic bile duct must be considered as an oncologically inefficient procedure.
引用
收藏
页码:194 / 200
页数:7
相关论文
共 26 条
[1]  
BHUIYA MMR, 1992, ANN SURG, V215, P344
[2]   MANAGEMENT STRATEGIES IN RESECTION FOR HILAR CHOLANGIOCARCINOMA [J].
BISMUTH, H ;
NAKACHE, R ;
DIAMOND, T .
ANNALS OF SURGERY, 1992, 215 (01) :31-38
[3]   SURGICAL ANATOMY AND ANATOMICAL SURGERY OF THE LIVER [J].
BISMUTH, H .
WORLD JOURNAL OF SURGERY, 1982, 6 (01) :3-9
[4]  
Born P, 1999, ENDOSCOPY, V31, P748
[5]  
HATFIELD ARW, 1982, LANCET, V2, P896
[6]   Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors [J].
Hintze, RE ;
Abou-Rebyeh, H ;
Adler, A ;
Veltzke-Schlieker, W ;
Felix, R ;
Wiedenmann, B .
GASTROINTESTINAL ENDOSCOPY, 2001, 53 (01) :40-46
[7]  
IWASAKI Y, 1986, SURG GYNECOL OBSTET, V162, P457
[8]   Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer [J].
Izbicki, JR ;
Hosch, SB ;
Pichlmeier, U ;
Rehders, A ;
Busch, C ;
Niendorf, A ;
Passlick, B ;
Broelsch, CE ;
Pantel, K .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (17) :1188-1194
[9]   Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma [J].
Jarnagin, WR ;
Fong, Y ;
DeMatteo, RP ;
Gonen, M ;
Burke, EC ;
Bodniewicz, J ;
Youssef, M ;
Klimstra, D ;
Blumgart, LH .
ANNALS OF SURGERY, 2001, 234 (04) :507-517
[10]   PERCUTANEOUS PALLIATION OF UNRESECTABLE PANCREATIC-CANCER [J].
KAUFMAN, SL .
SURGICAL CLINICS OF NORTH AMERICA, 1995, 75 (05) :989-&